DOXORUBICIN CARDIOTOXICITY MAY BE CAUSED BY ITS METABOLITE, DOXORUBICINOL

被引：327

作者：

OLSON, RD

MUSHLIN, PS

BRENNER, DE

FLEISCHER, S

CUSACK, BJ

CHANG, BK

BOUCEK, RJ

机构：

[1] UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA

[2] HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DEPT ANESTHESIA, BOSTON, MA 02115 USA

[3] VET ADM MED CTR, NASHVILLE, TN 37203 USA

[4] VANDERBILT UNIV, DEPT MED, NASHVILLE, TN 37232 USA

[5] VANDERBILT UNIV, DEPT MOLEC BIOL, NASHVILLE, TN 37232 USA

[6] VANDERBILT UNIV, DEPT PEDIAT, NASHVILLE, TN 37232 USA

[7] VANDERBILT UNIV, DEPT BIOCHEM, NASHVILLE, TN 37232 USA

[8] VET ADM MED CTR, AUGUSTA, GA 30904 USA

[9] MED COLL GEORGIA, DEPT MED, AUGUSTA, GA 30912 USA

来源：

关键词：

D O I：

10.1073/pnas.85.10.3585

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：3585 / 3589

页数：5

共 26 条

[1] DETERMINATION OF PHOSPHATE - STUDY OF LABILE ORGANIC PHOSPHATE INTERFERENCE
BAGINSKI, ES
FOA, PP
ZAK, B
[J]. CLINICA CHIMICA ACTA, 1967, 15 (01) : 155 - &
[2] IMPROVED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY OF DOXORUBICIN - DETECTION OF CIRCULATING AGLYCONES IN HUMAN-PLASMA AND COMPARISON WITH THIN-LAYER CHROMATOGRAPHY
BRENNER, DE
GALLOWAY, S
COOPER, J
NOONE, R
HANDE, KR
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (02) : 139 - 145
[3] CHAMBERLAIN BK, 1983, J BIOL CHEM, V258, P6602
[4] CHANG BK, 1982, CANCER RES, V42, P2666
[5] MIGHT ADRIAMYCINOL CONTRIBUTE TO ADRIAMYCIN-INDUCED CARDIOTOXICITY
DELTACCA, M
DANESI, R
DUCCI, M
BERNARDINI, C
ROMANINI, A
[J]. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1985, 17 (11): : 1073 - 1084
[6] DRESDALE A, 1983, CANCER, V52, P51, DOI 10.1002/1097-0142(19830701)52:1<51::AID-CNCR2820520111>3.0.CO
[7] 2-#
[8] FABIATO A, 1982, FED PROC, V41, P2238
[9] Fleischer S, 1974, Methods Enzymol, V31, P292
[10] Fleischer S., 1967, METHOD ENZYMOL, V10, P406